Arcutis 生物治療公司
US ˙ NasdaqGS ˙ US03969K1088

SecurityARQT / Arcutis Biotherapeutics, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership183,479 shares
Latest Disclosed Value $ 2,572,375
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series ownership in ARQT / Arcutis Biotherapeutics, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 183,479 shares of Arcutis Biotherapeutics, Inc. (US:ARQT) valued at $2,572,376 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 183,479 shares of Arcutis Biotherapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $3,895,259 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 183,479 0 0.00 2,572 -10.35 0.0578
2025-05-28 2025-03-31 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 183,479 158 0.09 2,870 12.38 0.0688
2025-02-25 2024-12-31 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 183,321 -27,102 -12.88 2,554 30.52 0.0558
2024-11-26 2024-09-30 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 210,423 63,008 42.74 1,957 42.77 0.0370
2024-08-26 2024-06-30 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 147,415 8,801 6.35 1,371 -0.22 0.0279
2024-05-28 2024-03-31 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 138,614 46,851 51.06 1,374 363.85 0.0287
2024-02-26 2023-12-31 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 91,763 7,240 8.57 296 -33.93 0.0063
2023-11-28 2023-09-30 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 84,523 -5,157 -5.75 449 -47.54 0.0117
2023-08-25 2023-06-30 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 89,680 22,854 34.20 855 16.19 0.0203
2023-05-26 2023-03-31 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 66,826 2,737 4.27 735 -22.47 0.0196
2023-02-24 2022-12-31 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 64,089 8 0.01 949 -22.55 0.0261
2022-11-25 2022-09-30 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 64,081 9,970 18.43 1,225 6.16 0.0351
2022-08-25 2022-06-30 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 54,111 10,584 24.32 1,153 37.59 0.0318
2022-05-26 2022-03-31 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 43,527 0 0.00 838 -7.10 0.0195
2022-02-25 2021-12-31 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 43,527 0 0.00 903 -13.19 0.0196
2021-11-24 2021-09-30 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 43,527 0 0.00 1,040 -12.47 0.0229
2021-08-26 2021-06-30 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 43,527 8,614 24.67 1,188 17.52 0.0255
2021-05-27 2021-03-31 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 34,913 1,852 5.60 1,010 8.60 0.0229
2021-02-25 2020-12-31 NP ARCUTIS BIOTHERAPEUTICS EC US03969K1088 33,061 3,891 13.34 930 8.90 0.0238
2020-11-25 2020-09-30 NP Arcutis Biotherapeutics EC US03969K1088 29,170 13,556 86.82 855 80.93 0.0274
2020-08-27 2020-06-30 NP Arcutis Biotherapeutics EC US03969K1088 15,614 -1,179 -7.02 472 -5.60 0.0154
2020-06-01 2020-03-31 NP Arcutis Biotherapeutics EC US03969K1088 16,793 16,793 500 0.0205
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.